S&P 500   4,269.40 (-0.43%)
DOW   33,322.55 (-0.55%)
QQQ   359.20 (+0.26%)
AAPL   173.13 (+1.12%)
MSFT   318.18 (+0.77%)
META   303.54 (+1.11%)
GOOGL   133.02 (+1.65%)
AMZN   128.72 (+1.26%)
TSLA   250.67 (+0.18%)
NVDA   446.80 (+2.72%)
NIO   8.78 (-2.88%)
BABA   86.25 (-0.56%)
AMD   102.73 (-0.09%)
T   14.82 (-1.33%)
F   12.25 (-1.37%)
MU   67.62 (-0.60%)
CGC   0.75 (-3.73%)
GE   108.63 (-1.74%)
DIS   81.16 (+0.14%)
AMC   7.96 (-0.38%)
PFE   33.56 (+1.18%)
PYPL   58.12 (-0.58%)
NFLX   378.72 (+0.30%)
S&P 500   4,269.40 (-0.43%)
DOW   33,322.55 (-0.55%)
QQQ   359.20 (+0.26%)
AAPL   173.13 (+1.12%)
MSFT   318.18 (+0.77%)
META   303.54 (+1.11%)
GOOGL   133.02 (+1.65%)
AMZN   128.72 (+1.26%)
TSLA   250.67 (+0.18%)
NVDA   446.80 (+2.72%)
NIO   8.78 (-2.88%)
BABA   86.25 (-0.56%)
AMD   102.73 (-0.09%)
T   14.82 (-1.33%)
F   12.25 (-1.37%)
MU   67.62 (-0.60%)
CGC   0.75 (-3.73%)
GE   108.63 (-1.74%)
DIS   81.16 (+0.14%)
AMC   7.96 (-0.38%)
PFE   33.56 (+1.18%)
PYPL   58.12 (-0.58%)
NFLX   378.72 (+0.30%)
S&P 500   4,269.40 (-0.43%)
DOW   33,322.55 (-0.55%)
QQQ   359.20 (+0.26%)
AAPL   173.13 (+1.12%)
MSFT   318.18 (+0.77%)
META   303.54 (+1.11%)
GOOGL   133.02 (+1.65%)
AMZN   128.72 (+1.26%)
TSLA   250.67 (+0.18%)
NVDA   446.80 (+2.72%)
NIO   8.78 (-2.88%)
BABA   86.25 (-0.56%)
AMD   102.73 (-0.09%)
T   14.82 (-1.33%)
F   12.25 (-1.37%)
MU   67.62 (-0.60%)
CGC   0.75 (-3.73%)
GE   108.63 (-1.74%)
DIS   81.16 (+0.14%)
AMC   7.96 (-0.38%)
PFE   33.56 (+1.18%)
PYPL   58.12 (-0.58%)
NFLX   378.72 (+0.30%)
S&P 500   4,269.40 (-0.43%)
DOW   33,322.55 (-0.55%)
QQQ   359.20 (+0.26%)
AAPL   173.13 (+1.12%)
MSFT   318.18 (+0.77%)
META   303.54 (+1.11%)
GOOGL   133.02 (+1.65%)
AMZN   128.72 (+1.26%)
TSLA   250.67 (+0.18%)
NVDA   446.80 (+2.72%)
NIO   8.78 (-2.88%)
BABA   86.25 (-0.56%)
AMD   102.73 (-0.09%)
T   14.82 (-1.33%)
F   12.25 (-1.37%)
MU   67.62 (-0.60%)
CGC   0.75 (-3.73%)
GE   108.63 (-1.74%)
DIS   81.16 (+0.14%)
AMC   7.96 (-0.38%)
PFE   33.56 (+1.18%)
PYPL   58.12 (-0.58%)
NFLX   378.72 (+0.30%)
NASDAQ:RDHL

RedHill Biopharma (RDHL) Earnings Date, Estimates & Call Transcripts

$0.48
-0.03 (-6.67%)
(As of 01:21 PM ET)
Compare
Today's Range
$0.48
▼
$0.52
50-Day Range
$0.51
▼
$1.36
52-Week Range
$0.48
▼
$38.40
Volume
129,161 shs
Average Volume
222,862 shs
Market Capitalization
$2.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Dec. 5Estimated
Actual EPS
(Aug. 17)
$36.00 Beat By $36.00
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

RDHL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RDHL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

RDHL Earnings Date and Information

RedHill Biopharma last released its quarterly earnings results on August 17th, 2023. The biotechnology company reported $36.00 EPS for the quarter. The company earned $1.80 million during the quarter. RedHill Biopharma has generated $0.00 earnings per share over the last year. RedHill Biopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, December 5th, 2023 based off prior year's report dates.

RedHill Biopharma Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
12/5/2023
Estimated)		------- 
8/17/2023Q2 2023-$36.00+$36.00$36.00-$1.80 million
6/12/2023Q1 2023-$5.87+$5.87($8.26)-$3.60 million
11/29/2022Q3 2022($12.00)($22.40)($10.40)($0.56)-$17.55 million
11/7/2022Q2 2022-($8.00)($8.00)($0.20)-$18.35 million
6/23/2022Q1 2022($16.00)($12.00)+$4.00($0.30)-$18.24 million    
3/17/2022Q4 2021($16.00)($20.00)($4.00)($0.50)$22.99 million$22.07 million    
11/30/2021Q3 2021($19.20)($20.00)($0.80)($0.46)$23.41 million$21.61 million    
8/25/2021Q2 2021($16.00)($24.00)($8.00)($0.62)$23.15 million$21.50 million    
5/26/2021Q1 2021($13.60)($2.00)+$11.60($0.53)$22.37 million$20.58 million  
3/17/2021Q4 2020($14.40)($28.00)($13.60)($0.70)$26.72 million$21.46 million  
11/17/2020Q3 2020($8.80)($20.00)($11.20)($0.50)$23.57 million$20.94 million  












RedHill Biopharma Earnings - Frequently Asked Questions

When is RedHill Biopharma's earnings date?

RedHill Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, December 5th, 2023 based off last year's report dates. Learn more on RDHL's earnings history.

How much revenue does RedHill Biopharma generate each year?

RedHill Biopharma (NASDAQ:RDHL) has a recorded annual revenue of $61.80 million.

How much profit does RedHill Biopharma generate each year?

RedHill Biopharma (NASDAQ:RDHL) has a recorded net income of -$71.67 million. RDHL has generated $0.00 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:RDHL) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -